Clinical Course Of Disease In Participants With FA-CM (NCT06865482)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (19 Sites)

• University of California San Diego — La Jolla, California
• University of South Florida — Tampa, Florida
• Indiana University - Riley Children's Health — Indianapolis, Indiana
• Boston Children's Hospital — Boston, Massachusetts
• Mayo Clinic — Rochester, Minnesota
• Washington University School of Medicine in St. Louis — St Louis, Missouri
• Cincinnati Children's Hospital — Cincinnati, Ohio
• Oregon Health & Science University — Portland, Oregon
• Hospital Universitário Walter Cantídio - Universidade Federal do Ceará — Fortaleza, Ceará
• Instituto D'or de Pesquisa e Ensino - Hospital São Rafael — Salvador, Estado de Bahia
• Hospital Das Clínicas Da Universidade Federal De Minas Gerais (UFMG) — Belo Horizonte, Minas Gerais
• Campinas State University (UNICAMP) — Campinas, São Paulo
• UPC Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto — Ribeirão Preto, São Paulo
• Centre Hospitalier de Universite de Montreal (CHUM) — Montreal, Quebec
• Motol University Hospital and the Second Faculty of Medicine — Prague,
• Institut de Cardiologie Hopital Pitie Salpetriere — Paris,
• University Hospital Tübingen — Tübingen, Baden-Wurttemberg
• Federico II University — Naples,
• Hospital Univeritario Puerta de Hierro de Majadahonda — Majadahonda, Madrid

📞 Contact the Study Coordinator

Phone: (212) 547-9879

Email: clinicaltrials@lexeotx.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Friedreich Ataxia

• A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old — Philadelphia, Pennsylvania
• A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich Ataxia (TRACK-FA) — Gainesville, Florida
• FA Clinical Outcome Measures — Los Angeles, California
• A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia — Los Angeles, California
• Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia — Los Angeles, California

Explore by condition: All Friedreich Ataxia clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.